BidaskClub reduced the company's shares Mazor Robotics (NASDAQ: MZOR) from a strong purchase rating to a purchase rating in a report released on Friday 2 November.
A number of other brokers also commented on the MZOR. Zacks Investment Research downgraded Mazor Robotics from its ratings for a sales rating in a report Wednesday, July 18. ValuEngine has downgraded Mazor Robotics's ratings of a strong purchasing purchase rating on a research report Tuesday, July 10. Needham & Company LLC confirmed on Thursday, August 2, the sale of shares of Mazor Robotics. Two analysts rated the shares with a sell rating, three issued a rating, two earned a rating, and one assigned a strong rating to buy the company. Mazor Robotics currently has a consensual Hold rating and an average price target of $ 59.90.
MZOR's shares remained at $ 58.30 on a trading session Friday. The stock exchange had a volume of trades of 205,785 shares compared to an average of 529,699 shares. The company has a market capitalization of $ 1.53 billion, a price / yield ratio of -116.60 and a beta version of 1.32. Mazor Robotics has a 52-week minimum of $ 41.60 and a 52-week maximum of $ 76.56.
Several large investors have recently added or decreased their shares in the MZOR. In the 1st quarter, LPL Financial LLC increased its position in Mazor Robotics by 39.0%. LPL Financial LLC now owns 7789 stock of US $ 478,000 medical device suppliers after having purchased 2,185 more units during the period. The Royal Bank of Canada increased its position in Mazor Robotics by 2.5% in Q1. The Royal Bank of Canada now owns 65,319 shares of a supplier of medical devices worth USD 4,008,000 after buying another 1,606 shares per period. New England Research & Management Inc. earned a new position in Mazor Robotics's share of $ 255,000 in Q2. The US National Bank increased its position in Mazor Robotics by 47.3% in Q2. The US National Bank now holds 6,473 shares of a $ 359,000 medical device supplier after the purchase of another 2,079 units during the period. In the second quarter, Dorsey Wright & Associates increased its position in Mazor Robotics by 16.9%. Dorsey Wright & Associates now owns 192,549 shares of a $ 10,648,000 medical device supplier after having purchased another 27,809 stock for that period. Institutional investors and hedge funds own 22.63% of the company's shares.
About Mazor Robotics
Mazor Robotics Ltd. together with its subsidiaries, is engaged in the development, manufacture and marketing of medical devices for the promotion of surgical procedures in the field of orthopedics and neurosurgery in the United States and internationally. He works in the field of computer surgery, which allows the use of surgical instruments with high precision and minimal invasiveness and simplifies complex surgical procedures.
Recommended story: Does the discount rate affect the economy?
Get news and ratings for Mazor Robotics Daily – Enter your e-mail address below and get a brief daily summary of the latest reports and ratings of Mazor Robotics analysts and related companies with MarketBeat.com's daily e-mail newsletter.